Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Ostrowiec Swietokrzyski – page 7

80 clinical trials in Ostrowiec Swietokrzyski, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Ostrowiec Swietokrzyski at a glance
80
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

80 trials in Ostrowiec Swietokrzyski

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.

Asthma

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.

Bronchiectasis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

Hidradenitis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.

Neurodermatitis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Other cities in Poland

The busiest research cities in the country

All 238 cities in Poland

Clinical research in Ostrowiec Swietokrzyski

What the registry says about research in the country

01 Respiratory Conditions

Important clinical research focusing on asthma and COPD management, including trials evaluating new inhaler formulations and innovative treatments for severe cases.

  • Asthma control and exacerbation prevention
  • COPD treatment optimization
  • Bronchiectasis management

Studies include evaluation of triple therapy combinations and novel biological treatments for better disease control.

02 Dermatological Disorders

Comprehensive research into various skin conditions, with particular focus on atopic dermatitis, psoriasis, and other inflammatory skin disorders.

  • Moderate to severe plaque psoriasis
  • Atopic dermatitis treatments
  • Vitiligo and alopecia therapies

Trials examine both topical and systemic treatments, including novel biological therapies.

03 Cardiovascular Research

Innovative studies targeting atherosclerotic cardiovascular disease, focusing on prevention and treatment of major cardiovascular events.

  • Lipid-modifying therapies
  • Cardiovascular risk reduction
  • Prevention of major adverse cardiac events

Research includes evaluation of new compounds for managing cholesterol levels and preventing cardiovascular complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.